Setting new standards in information exchange for the pharmaceutical and biotech industry
Pfizer’s “Blue Sky” Team Featured on PharmaTalkRadio
August 23, 2016
Members of Pfizer’s “Blue Sky” team join DPharm’s Director, Valerie Bowling and Clinical Leader’s Chief Editor, Ed Miseta on PharmaTalkRadio to discuss the work they are doing to transform clinical research in Parkinson’s disease and patient-centric innovation. Together they discuss the vision, goals and journey in taking a new approach to advancing drug development.
More specifically, the Blue Sky team talks about their partnership with IBM, the first of its kind research collaboration, decisions on how to use a device in a trial, real time data collection, an 1800s house for a 21st Century research and more.
Pfizer’s Blue Sky Guests:
Stephen Amato, PhD, Project Manager, BlueSky, Pfizer
David Caouette, MBA, Senior Director, Strategy and Operations Lead, BlueSky and Quantitative Medicine, Pfizer
Daniel Karlin, MD, Senior Director, Quantitative Medicine, Clinical Lead, BlueSky, Pfizer
Both Drs David Caouette and Daniel Karlin are co-presenting at the DPharm conference on September 20th in Boston. For more information go to www.theconferenceforum.org.
Click here to hear the radio program: http://www.blogtalkradio.com/pharmatalk/2016/08/10/pfizers-blue-sky-approach-to-help-transform-clinical-research-1